News

Targeted Oncology1d
FDA Approves Zanubrutinib Tablet for All Indications
The FDA has approved a tablet version of zanubrutinib for all indications, improving convenience and reducing pill burden for ...
Sunshine Biopharma Launches Generic Gabapentin for Neuropathic Pain in the Canadian Segment of the Global $1.92 Billion Market
FORT LAUDERDALE, FL / ACCESS Newswire / June 11, 2025 / Sunshine Biopharma Inc. (NASDAQ:SBFM) (the "Company"), a ...